CCCC: C4 Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 101.87
Enterprise Value ($M) 46.37
Book Value ($M) 215.99
Book Value / Share 3.04
Price / Book 0.47
NCAV ($M) 124.15
NCAV / Share 1.75
Price / NCAV 0.82

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.41

Liquidity (mrq)
Quick Ratio 5.71
Current Ratio 5.71

Balance Sheet (mrq) ($M)
Current Assets 257.77
Assets 349.60
Liabilities 133.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 35.58
Operating Income -117.18
Net Income -105.32

Cash Flow Statement (mra) ($M)
Cash From Operations -65.16
Cash from Investing -51.27
Cash from Financing 45.34

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-03 13G Morgan Stanley 5.40
11-14 13G/A Lynx1 Capital Management LP 9.90 119.52
11-14 13G/A Soleus Capital Master Fund, L.P. 9.40 158.37
11-14 13G Orbimed Advisors Llc 4.20
11-14 13G/A Commodore Capital Lp 4.80 -10.25
11-14 13G/A Price T Rowe Associates Inc /md/ 0.60 -84.68
11-14 13G/A Point72 Asset Management, L.P. 1.90 -50.92
11-08 13G BlackRock, Inc. 7.10 0.00
07-10 13G/A State Street Corp 4.35 -58.13
2024-03-08 13G/A Wasatch Advisors Inc

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 314,390 717,371 43.83
2025-04-01 348,491 817,885 42.61
2025-03-31 396,266 832,412 47.60
2025-03-28 150,280 447,817 33.56

(click for more detail)

Similar Companies
BMRN – BioMarin Pharmaceutical Inc. BPMC – Blueprint Medicines Corporation
CABA – Cabaletta Bio, Inc. CGC – Canopy Growth Corporation
CGEM – Cullinan Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io